Summary
Thermo Fisher Scientific Inc. (TMO) announced on July 16, 2015, its entry into an underwriting agreement for the issuance and sale of €500,000,000 aggregate principal amount of 2.150% Senior Notes due 2022. This offering is being conducted under a previously filed registration statement on Form S-3. The company anticipates net proceeds of approximately €496 million after accounting for underwriting discounts and estimated offering expenses. These proceeds are designated for general corporate purposes, providing flexibility for ongoing business operations and strategic initiatives.
Key Highlights
- 1Thermo Fisher Scientific issued €500 million in Senior Notes due 2022.
- 2The notes carry a coupon rate of 2.150%.
- 3The offering is a public offering under a Form S-3 registration statement.
- 4Estimated net proceeds are approximately €496 million.
- 5Proceeds are intended for general corporate purposes.
- 6The issuance was facilitated by an underwriting agreement with BNP Paribas and HSBC Bank plc.
- 7The notes will be governed by an existing indenture, supplemented by a Ninth Supplemental Indenture.
Frequently Asked Questions
Thermo Fisher Scientific intends to use the net proceeds from this offering for general corporate purposes. This provides the company with financial flexibility for its ongoing operations, investments, or other strategic needs.
The Senior Notes due 2022 have a fixed coupon rate of 2.150% and will mature in 2022.
The lead managers for this issuance are BNP Paribas and HSBC Bank plc.
Thermo Fisher Scientific expects to receive approximately €496 million in net proceeds after deducting underwriting discounts and estimated offering expenses.